Prostaglandin Synthetase Inhibitors as Immunoadjuvants in the Treatment of Cancer
- 1 January 1980
- journal article
- research article
- Published by Taylor & Francis in Journal of Immunopharmacology
- Vol. 2 (4) , 397-424
- https://doi.org/10.3109/08923978009026403
Abstract
(1980). Prostaglandin Synthetase Inhibitors as Immunoadjuvants in the Treatment of Cancer. Journal of Immunopharmacology: Vol. 2, No. 4, pp. 397-424. doi: 10.3109/08923978009026403Keywords
This publication has 90 references indexed in Scilit:
- Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.Journal of Clinical Investigation, 1980
- Indomethacin-responsive mononuclear cell dysfunction in Hodgkin's diseaseClinical Immunology and Immunopathology, 1980
- Prostaglandin A Compounds as Antiviral AgentsScience, 1980
- Regulation of the immune response by prostaglandinsClinical Immunology and Immunopathology, 1980
- Effect of indomethacin on blastogenesis of lymphocytes from cancer patients: Differentiation of patient typesClinical Immunology and Immunopathology, 1979
- Prostaglandins as regulators in cellular immunityProstaglandins and Medicine, 1978
- Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cellsCellular Immunology, 1978
- Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.The Journal of Experimental Medicine, 1978
- PROSTAGLANDINS AND BREAST CANCERThe Lancet, 1977
- Adherence of Human Peripheral Blood Lymphocytes to Measles-Infected CellsNew England Journal of Medicine, 1977